GLYPH2BLSD Trademark

Serial Number: 99336889

GLYPH2BLSD is a trademark filed by Seaport Therapeutics, Inc. on August 14, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 35 - Advertising & Business

Advertising; business management; business administration; office functions

Owner Contact Info

Seaport Therapeutics, Inc. (13 trademarks)

6 Tide St.
Boston, MA 02210

Entity Type: 03

Legal Representation

Attorney of Record

Nicholas B. Hawkins

259 trademarks filed View all →

Correspondence Address

Nicholas B. Hawkins Womble Bond Dickinson (US) LLP

888 Seventh Avenue

38th Floor

New York, NY 10106

United States

Trademark Details

Filing Date

August 14, 2025

Registration Date

Not Registered

Published for Opposition

January 27, 2026

Goods & Services

Commercialization, namely, commercial consultancy in the pharmaceutical and biotechnology fields

Research and development in the pharmaceutical and biotechnology fields; medical and scientific research in the field of clinical trials

Technologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases